15-71826576-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_006901.4(MYO9A):c.*4G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000259 in 1,573,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )
Consequence
MYO9A
NM_006901.4 3_prime_UTR
NM_006901.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.264
Genes affected
MYO9A (HGNC:7608): (myosin IXA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-9 (MYH9). Unconventional myosins contain the basic domains of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with Bardet-Biedl Syndrome. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 15-71826576-C-T is Benign according to our data. Variant chr15-71826576-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3356719.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO9A | NM_006901.4 | c.*4G>A | 3_prime_UTR_variant | 42/42 | ENST00000356056.10 | NP_008832.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO9A | ENST00000356056.10 | c.*4G>A | 3_prime_UTR_variant | 42/42 | 1 | NM_006901.4 | ENSP00000348349 | P2 | ||
MYO9A | ENST00000561618.5 | c.*4G>A | 3_prime_UTR_variant | 19/19 | 1 | ENSP00000457945 | ||||
MYO9A | ENST00000564571.5 | c.*456G>A | 3_prime_UTR_variant | 42/42 | 1 | ENSP00000456192 | A2 | |||
MYO9A | ENST00000568042.5 | c.*4G>A | 3_prime_UTR_variant | 9/9 | 5 | ENSP00000457407 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 206AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
206
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000424 AC: 92AN: 216956Hom.: 0 AF XY: 0.000326 AC XY: 38AN XY: 116428
GnomAD3 exomes
AF:
AC:
92
AN:
216956
Hom.:
AF XY:
AC XY:
38
AN XY:
116428
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000137 AC: 195AN: 1421176Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 87AN XY: 704322
GnomAD4 exome
AF:
AC:
195
AN:
1421176
Hom.:
Cov.:
31
AF XY:
AC XY:
87
AN XY:
704322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00139 AC: 212AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.00140 AC XY: 104AN XY: 74480
GnomAD4 genome
AF:
AC:
212
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
104
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MYO9A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 21, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at